Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Pacira reported $-20017000 in Operating Profit for its fiscal quarter ending in March of 2023.

Operating Profit Change
AmerisourceBergen ABC:US USD 560.52M 72.62M
Astellas Pharma 4503:JP JPY -48250000000 109.64B
Bristol-Myers Squibb BMY:US USD 3.1B 1.15B
Cara Therapeutics CARA:US USD -27650000 3.66M
Coherus Biosciences CHRS:US USD -67745000 16.25M
Depomed DEPO:US USD 4.64M 5.98M
Endo International ENDP:US USD 3.46M 240.32M
Heron Therapeutics HRTX:US USD -33063000 12.71M
Horizon Pharma HZNP:US USD 35.99M 137.94M
Ironwood Pharmaceuticals IRWD:US USD 60.1M 8.27M
J&J JNJ:US USD -737000000 4.94B
Ligand Pharmaceuticals LGND:US USD 14.2M 2.03M
Nektar Therapeutics NKTR:US USD -134710000 82.24M
Pacira PCRX:US USD -20017000 10.12M
Perrigo PRGO:US USD 48.5M 17.5M
Pfizer PFE:US USD 6.79B 1.62B
Revance Therapeutics RVNC:US USD -58032000 86.38M
Supernus Pharmaceuticals SUPN:US USD 5.18M 29.16M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 2M 857M
Xoma XOMA:US USD -10170000 3.96M
Zoetis ZTS:US USD 697M 105M